Category: News

IDH1 mutation induces reprogramming of pyruvate metabolism

Mutant isocitrate dehydrogenase 1 (IDH1) catalyzes the production of 2-hydroxyglutarate but also elicits additional metabolic changes. Levels of both glutamate and pyruvate dehydrogenase (PDH) activity have been shown to be affected in U87 glioblastoma...

IDH1 Mutation Downregulates Pyruvate Dehydrogenase Activity

Mutant isocitrate dehydrogenase 1 (IDH1) catalyzes the production of 2-hydroxyglutarate but also elicits additional metabolic changes. Levels of both glutamate and pyruvate dehydrogenase (PDH) activity have been shown to be affected in U87 glioblastoma...

KIAA1324 suppresses gastric cancer progression by inhibiting the oncoprotein GRP78

Recent advances in genome and transcriptome analysis have contributed to the identification of many potential cancer-related genes. Furthermore, biological and clinical investigations of the candidate genes provide us with a better understanding of car...

KIAA1324, a Novel Gastric Tumor Suppressor

Recent advances in genome and transcriptome analysis have contributed to the identification of many potential cancer-related genes. Furthermore, biological and clinical investigations of the candidate genes provide us with a better understanding of car...

PML/RAR{alpha} -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia

In acute promyelocytic leukemia (APL), all-trans-retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. MicroRNA are known to be critical players in the formation of the leukemic phenotype. In this study, we ...